InvaGen Pharmaceuticals, Inc.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Avenue Therapeutics Inc (ATXI)

Transaction date 11 Oct 2022

Sale

Price

22.31

Quantity 9,500 -20.0%

Value US$743,202

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-10-13	2022-10-11	Avenue Therapeutics Inc (ATXI)	S Sale	9,500 -20.0% 22.31 US$743,202	9,500 -20.0%	22.31	US$743,202